Publications by authors named "G Venton"

Claim this Profile
A
Assessment of Systematic JAK2V617F Screening in 996 Patients With Venous Thromboembolism.
Norman Abbou, Julie Quessada, Antoine Tichadou, Robin Arcani, Régis Costello, Geoffroy Venton

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the toxicity-efficacy ratio of venetoclax in real-world patients.
Loïc Osanno, Lucy Brocque, Laurent Bourguignon, Carla Delpech, Laure Farnault, Geoffroy Venton

Ann Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of patients with accelerated and blast-phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination-A FIM study.
Corentin Orvain, Suzanne Tavitian, Clémence Mediavilla, Françoise Boyer, Alberto Santagostino, Geoffroy Venton

Hemasphere· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of CDA Dynamics on Clinical Outcome of Patients With AML or High-Risk MDS Treated With Nucleoside Analogs.
Erwann Collomb, Laurent Bourguignon, Antoine Tichadou, Pauline Roche, Guillaume Berton, Geoffroy Venton

Hematol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index affects imatinib exposure: Real-world evidence from TDM with adaptive dosing.
Paul Maroselli, Raphaelle Fanciullino, Julien Colle, Laure Farnault, Pauline Roche, Geoffroy Venton

Fundam Clin Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis